Slingerland JM - Search Results

1

Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.

Zhang W, Kapusta LR, Slingerland JM, Klotz LH. Zhang W, et al. Among authors: slingerland jm. Cancer Res. 1998 Feb 15;58(4):619-21. Cancer Res. 1998. PMID: 9485010

2

C-terminally phosphorylated p27 activates self-renewal driver genes to program cancer stem cell expansion, mammary hyperplasia and cancer.

Razavipour SF, Yoon H, Jang K, Kim M, Nawara HM, Bagheri A, Huang WC, Shin M, Zhao D, Zhou Z, Van Boven D, Briegel K, Morey L, Ince TA, Johnson M, Slingerland JM. Razavipour SF, et al. Among authors: slingerland jm. Nat Commun. 2024 Jun 17;15(1):5152. doi: 10.1038/s41467-024-48742-y. Nat Commun. 2024. PMID: 38886396 Free PMC article.

3

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.

Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI, Slingerland JM. Catzavelos C, et al. Among authors: slingerland jm. Nat Med. 1997 Feb;3(2):227-30. doi: 10.1038/nm0297-227. Nat Med. 1997. PMID: 9018244

4

Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.

Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM. Tsihlias J, et al. Among authors: slingerland jm. Cancer Res. 1998 Feb 1;58(3):542-8. Cancer Res. 1998. PMID: 9458103

5

Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras.

Catzavelos C, Tsao MS, DeBoer G, Bhattacharya N, Shepherd FA, Slingerland JM. Catzavelos C, et al. Among authors: slingerland jm. Cancer Res. 1999 Feb 1;59(3):684-8. Cancer Res. 1999. PMID: 9973218

6

Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1.

Cariou S, Catzavelos C, Slingerland JM. Cariou S, et al. Among authors: slingerland jm. Breast Cancer Res Treat. 1998;52(1-3):29-41. doi: 10.1023/a:1006154900130. Breast Cancer Res Treat. 1998. PMID: 10066070 Review.

7

The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer.

Tsihlias J, Kapusta L, Slingerland J. Tsihlias J, et al. Annu Rev Med. 1999;50:401-23. doi: 10.1146/annurev.med.50.1.401. Annu Rev Med. 1999. PMID: 10073286 Review.

8

Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.

Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J. Tsihlias J, et al. Oncogene. 2000 Feb 3;19(5):670-9. doi: 10.1038/sj.onc.1203369. Oncogene. 2000. PMID: 10698512

9

p16INK4A mediates cyclin dependent kinase 4 and 6 inhibition in senescent prostatic epithelial cells.

Sandhu C, Peehl DM, Slingerland J. Sandhu C, et al. Cancer Res. 2000 May 15;60(10):2616-22. Cancer Res. 2000. PMID: 10825132

10

Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.

Chappuis PO, Kapusta L, Bégin LR, Wong N, Brunet JS, Narod SA, Slingerland J, Foulkes WD. Chappuis PO, et al. J Clin Oncol. 2000 Dec 15;18(24):4045-52. doi: 10.1200/JCO.2000.18.24.4045. J Clin Oncol. 2000. PMID: 11118465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters